MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

MDT

86.08

+0.56%↑

A

121.65

+2.99%↑

VEEV

167.9

+0.35%↑

HQY

85.93

+1.81%↑

NEOG

9.5

+2.81%↑

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

11.13 2.49

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.05

Max

11.44

Chiffres clés

By Trading Economics

Revenu

3.7M

-1.7M

Ventes

33M

435M

Marge bénéficiaire

-0.392

Employés

4,427

EBITDA

12M

66M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

+1.48% upside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-118M

798M

Ouverture précédente

8.64

Clôture précédente

11.13

Sentiment de l'Actualité

By Acuity

67%

33%

313 / 348 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 avr. 2026, 20:26 UTC

Acquisitions, Fusions, Rachats

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17 avr. 2026, 18:15 UTC

Principaux Événements d'Actualité

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17 avr. 2026, 16:49 UTC

Principaux Événements d'Actualité

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17 avr. 2026, 16:49 UTC

Principaux Événements d'Actualité

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17 avr. 2026, 22:58 UTC

Résultats

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 avr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 avr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 avr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17 avr. 2026, 20:52 UTC

Résultats

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 avr. 2026, 20:50 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

17 avr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 avr. 2026, 20:29 UTC

Résultats

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17 avr. 2026, 20:11 UTC

Acquisitions, Fusions, Rachats

UCB to Buy Neurona Therapeutics for Up to $1.15B

17 avr. 2026, 19:34 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Global Equities Roundup: Market Talk

17 avr. 2026, 19:34 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17 avr. 2026, 19:31 UTC

Market Talk
Principaux Événements d'Actualité

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17 avr. 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17 avr. 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17 avr. 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 avr. 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 avr. 2026, 18:57 UTC

Principaux Événements d'Actualité

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17 avr. 2026, 18:53 UTC

Acquisitions, Fusions, Rachats

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17 avr. 2026, 18:53 UTC

Acquisitions, Fusions, Rachats

UCB 2026 Rev Guidance Unchanged

17 avr. 2026, 18:52 UTC

Acquisitions, Fusions, Rachats

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17 avr. 2026, 18:52 UTC

Acquisitions, Fusions, Rachats

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17 avr. 2026, 18:14 UTC

Market Talk
Principaux Événements d'Actualité

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17 avr. 2026, 18:00 UTC

Principaux Événements d'Actualité

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17 avr. 2026, 18:00 UTC

Principaux Événements d'Actualité

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17 avr. 2026, 17:31 UTC

Market Talk
Principaux Événements d'Actualité

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17 avr. 2026, 17:26 UTC

Market Talk
Résultats

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

1.48% hausse

Prévisions sur 12 Mois

Moyen 11 USD  1.48%

Haut 12 USD

Bas 9 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

6 ratings

0

Achat

4

Maintien

2

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

313 / 348Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat